Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Non-Hodgkins
USOR Number: 11282

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: NA
USOR Number: 19208

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Essential Thrombocythemia

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

207495: A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide plus Low-dose Dexamethasone (pom/dex) in Participants with Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM3)

  • Details

ClinicalTrials.gov ID: NCT04162210
Diagnosis Type: NA
USOR Number: 18229

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

ENGOT-ov50 / INNOVATE-3: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant with Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer

  • Details

ClinicalTrials.gov ID: NCT03940196
Diagnosis Type: NA
USOR Number: 18269

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Uterine Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Colon Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Sarcoma

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Penile Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Vaginal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Bone Mets

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Kaposi's Sarcoma

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, Colorado 80907
510.37 mi. away
P: (719) 577-2555

More Details View Practice Page

Pages